Purification of Advanced Therapeutics by Flow‐Through Pseudo‐Affinity Chromatography: Bi‐Specific mABs, Fc Fusion Proteins, and Adeno‐Associated Viruses
Wenning Chu,
Eduardo Barbieri,
Arianna Minzoni,
Shriarjun Shastry,
Jacob P. LeBarre,
Qingbo Shu,
Taufika Williams,
Xuanwen Li,
Divya Chandra,
Xuankuo Xu,
Jerome Bill,
David Roush,
Joseph Taris,
Patrick Gilbert,
Andre Kiesewetter,
Oliver Rammo,
Michael Schulte,
Christopher Major,
Trina Mouchahoir,
Steven Cramer,
Cristiana Boi,
Ruben G. Carbonell,
Abraham Lenhoff,
Stefano Menegatti Biotechnology and Bioengineering
· Wiley
· 2026-10-14
· DOI: 10.1002/bit.70310
The publisher did not provide an abstract — full text is available via the link below.
Wenning Chu, Eduardo Barbieri, Arianna Minzoni, Shriarjun Shastry, Jacob P. LeBarre, Qingbo Shu et al. Purification of Advanced Therapeutics by Flow‐Through Pseudo‐Affinity Chromatography: Bi‐Specific mABs, Fc Fusion Proteins, and Adeno‐Associated Viruses. // Biotechnology and Bioengineering. – 2026. – DOI: 10.1002/bit.70310. – URL: https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.70310?af=R
Wenning Chu, Eduardo Barbieri, Arianna Minzoni, Shriarjun Shastry, Jacob P. LeBarre, Qingbo Shu, Taufika Williams, Xuanwen Li, Divya Chandra, Xuankuo Xu, Jerome Bill, David Roush, Joseph Taris, Patrick Gilbert, Andre Kiesewetter, Oliver Rammo, Michael Schulte, Christopher Major, Trina Mouchahoir, Steven Cramer, Cristiana Boi, Ruben G. Carbonell, Abraham Lenhoff, & Stefano Menegatti (2026). Purification of Advanced Therapeutics by Flow‐Through Pseudo‐Affinity Chromatography: Bi‐Specific mABs, Fc Fusion Proteins, and Adeno‐Associated Viruses. Biotechnology and Bioengineering. https://doi.org/10.1002/bit.70310
Wenning Chu, et al. “Purification of Advanced Therapeutics by Flow‐Through Pseudo‐Affinity Chromatography: Bi‐Specific mABs, Fc Fusion Proteins, and Adeno‐Associated Viruses.” Biotechnology and Bioengineering, 2026. doi:10.1002/bit.70310.
@article{Chu2026,
title = {Purification of Advanced Therapeutics by Flow‐Through Pseudo‐Affinity Chromatography: Bi‐Specific mABs, Fc Fusion Proteins, and Adeno‐Associated Viruses},
author = {Chu, Wenning and Barbieri, Eduardo and Minzoni, Arianna and Shastry, Shriarjun and LeBarre, Jacob P. and Shu, Qingbo and Williams, Taufika and Li, Xuanwen and Chandra, Divya and Xu, Xuankuo and Bill, Jerome and Roush, David and Taris, Joseph and Gilbert, Patrick and Kiesewetter, Andre and Rammo, Oliver and Schulte, Michael and Major, Christopher and Mouchahoir, Trina and Cramer, Steven and Boi, Cristiana and Carbonell, Ruben G. and Lenhoff, Abraham and Menegatti, Stefano},
journal = {Biotechnology and Bioengineering},
year = {2026},
doi = {10.1002/bit.70310},
url = {https://analyticalsciencejournals.onlinelibrary.wiley.com/doi/10.1002/bit.70310?af=R}
}
The growing recognition of base editing as a precise genome-engineering strategy for single‑nucleotide conversions without double‑strand breaks has increased interest in its application to animal agriculture, where many economically...
Sensorineural hearing loss (SNHL) is a prevalent auditory disorder, with noise exposure being its primary etiological factor; however, its molecular mechanisms and therapeutic targets remain poorly understood. This study integrated...
Nature Biotechnology, Published online: 16 November 2026; doi:10.1038/s41587-026-03344-5 Adeno-associated virus vectors targeted to CD7 enable T and NK cell engineering in vivo.